Quick Answer
Fortress Biotech, Inc. reported Shares Outstanding of 31.36 million shares for fiscal year 2025.
Fortress Biotech, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 31.36M | +12.4% |
| 2024 | 27.91M | +84.9% |
| 2023 | 15.09M | +104.9% |
| 2022 | 7.37M | -92.7% |
| 2021 | 101.44M | +6.9% |
| 2020 | 94.88M | +28.2% |
| 2019 | 74.03M | +28.0% |
| 2018 | 57.85M | +13.4% |
| 2017 | 50.99M | +4.2% |
| 2016 | 48.93M | +3.8% |
| 2015 | 47.15M | +1.4% |
| 2014 | 46.49M | +17.3% |
| 2013 | 39.65M | +62.5% |
| 2012 | 24.40M | +31.2% |
| 2011 | 18.60M | +288.3% |
| 2010 | 4.79M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 31.01M | +12.4% | +4.2% |
| June 30, 2025 | 29.75M | +31.7% | +0.7% |
| March 31, 2025 | 29.55M | +52.5% | +5.9% |
| December 31, 2024 | 27.91M | +84.9% | +1.2% |
| September 30, 2024 | 27.58M | +208.6% | +22.1% |
| June 30, 2024 | 22.59M | -82.8% | +16.6% |
| March 31, 2024 | 19.38M | -85.1% | +28.4% |
| December 31, 2023 | 15.09M | +104.9% | +68.9% |
- Fortress Biotech, Inc. showed an increase of +12.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Fortress Biotech, Inc.’s shares outstanding has grown by 554.6% (from 4.79 million shares to 31.36 million shares).
- The most recent figure is from Fortress Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: